nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.37	1	CiPCiCtD
Doxorubicin—thyroid cancer—germ cell cancer	0.0505	0.161	CtDrD
Doxorubicin—uterine cancer—germ cell cancer	0.0417	0.133	CtDrD
Doxorubicin—bone cancer—germ cell cancer	0.0374	0.119	CtDrD
Doxorubicin—ovarian cancer—germ cell cancer	0.0331	0.105	CtDrD
Doxorubicin—muscle cancer—germ cell cancer	0.0331	0.105	CtDrD
Doxorubicin—pancreatic cancer—germ cell cancer	0.0331	0.105	CtDrD
Doxorubicin—testicular cancer—germ cell cancer	0.031	0.0989	CtDrD
Doxorubicin—peripheral nervous system neoplasm—germ cell cancer	0.0274	0.0874	CtDrD
Doxorubicin—sarcoma—germ cell cancer	0.0264	0.0841	CtDrD
Doxorubicin—ABCC6—Dactinomycin—germ cell cancer	0.0258	0.123	CbGbCtD
Doxorubicin—NQO1—Cisplatin—germ cell cancer	0.0177	0.0843	CbGbCtD
Doxorubicin—ABCC6—Vinblastine—germ cell cancer	0.0162	0.0769	CbGbCtD
Doxorubicin—ABCC6—Cisplatin—germ cell cancer	0.0148	0.0705	CbGbCtD
Doxorubicin—ABCC6—Etoposide—germ cell cancer	0.0146	0.0693	CbGbCtD
Doxorubicin—ABCC10—Etoposide—germ cell cancer	0.0111	0.0529	CbGbCtD
Doxorubicin—XDH—Cisplatin—germ cell cancer	0.00927	0.0441	CbGbCtD
Doxorubicin—TOP2A—Etoposide—germ cell cancer	0.00776	0.0369	CbGbCtD
Doxorubicin—ABCC1—Dactinomycin—germ cell cancer	0.00762	0.0362	CbGbCtD
Doxorubicin—ABCC10—Methotrexate—germ cell cancer	0.00736	0.035	CbGbCtD
Doxorubicin—ABCC3—Cisplatin—germ cell cancer	0.00713	0.0339	CbGbCtD
Doxorubicin—ABCC3—Etoposide—germ cell cancer	0.007	0.0333	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—germ cell cancer	0.00672	0.0319	CbGbCtD
Doxorubicin—ABCG2—Dactinomycin—germ cell cancer	0.0051	0.0242	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—germ cell cancer	0.00477	0.0227	CbGbCtD
Doxorubicin—ABCC3—Methotrexate—germ cell cancer	0.00463	0.022	CbGbCtD
Doxorubicin—ABCC1—Etoposide—germ cell cancer	0.0043	0.0204	CbGbCtD
Doxorubicin—CYP2B6—Ifosfamide—germ cell cancer	0.00423	0.0201	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—germ cell cancer	0.00353	0.0168	CbGbCtD
Doxorubicin—ABCC2—Cisplatin—germ cell cancer	0.00324	0.0154	CbGbCtD
Doxorubicin—ABCC2—Etoposide—germ cell cancer	0.00318	0.0151	CbGbCtD
Doxorubicin—ABCG2—Cisplatin—germ cell cancer	0.00293	0.0139	CbGbCtD
Doxorubicin—ABCG2—Etoposide—germ cell cancer	0.00288	0.0137	CbGbCtD
Doxorubicin—ABCC1—Methotrexate—germ cell cancer	0.00284	0.0135	CbGbCtD
Doxorubicin—ABCC2—Methotrexate—germ cell cancer	0.0021	0.01	CbGbCtD
Doxorubicin—CYP2B6—Cisplatin—germ cell cancer	0.00206	0.00979	CbGbCtD
Doxorubicin—ABCG2—Methotrexate—germ cell cancer	0.0019	0.00904	CbGbCtD
Doxorubicin—ABCB1—Dactinomycin—germ cell cancer	0.00184	0.00874	CbGbCtD
Doxorubicin—CYP3A4—Ifosfamide—germ cell cancer	0.0013	0.00618	CbGbCtD
Doxorubicin—ABCB1—Vinblastine—germ cell cancer	0.00115	0.00548	CbGbCtD
Doxorubicin—CYP2D6—Vinblastine—germ cell cancer	0.00108	0.00516	CbGbCtD
Doxorubicin—ABCB1—Cisplatin—germ cell cancer	0.00106	0.00502	CbGbCtD
Doxorubicin—ABCB1—Etoposide—germ cell cancer	0.00104	0.00493	CbGbCtD
Doxorubicin—CYP3A4—Vinblastine—germ cell cancer	0.00069	0.00328	CbGbCtD
Doxorubicin—ABCB1—Methotrexate—germ cell cancer	0.000685	0.00326	CbGbCtD
Doxorubicin—CYP3A4—Etoposide—germ cell cancer	0.000622	0.00296	CbGbCtD
Doxorubicin—ABCC6—Podofilox—Etoposide—germ cell cancer	0.00019	0.154	CbGdCrCtD
Doxorubicin—NQO1—Vincristine—Vinblastine—germ cell cancer	0.000177	0.144	CbGdCrCtD
Doxorubicin—CBR3—Teniposide—Etoposide—germ cell cancer	0.000171	0.139	CbGdCrCtD
Doxorubicin—AKR1C3—Podofilox—Etoposide—germ cell cancer	0.000166	0.135	CbGdCrCtD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—germ cell cancer	0.000142	0.115	CbGdCrCtD
Doxorubicin—CBR1—Vincristine—Vinblastine—germ cell cancer	0.000108	0.088	CbGdCrCtD
Doxorubicin—AURKA—Teniposide—Etoposide—germ cell cancer	9e-05	0.0731	CbGdCrCtD
Doxorubicin—CBR1—skin of body—germ cell cancer	8.72e-05	0.00256	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—germ cell cancer	8.71e-05	0.00255	CbGeAlD
Doxorubicin—CBR1—decidua—germ cell cancer	8.66e-05	0.00254	CbGeAlD
Doxorubicin—DHCR7—adrenal gland—germ cell cancer	8.59e-05	0.00252	CbGeAlD
Doxorubicin—AKR1C3—decidua—germ cell cancer	8.55e-05	0.00251	CbGeAlD
Doxorubicin—NDUFS2—female gonad—germ cell cancer	8.53e-05	0.0025	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—germ cell cancer	8.51e-05	0.0025	CbGeAlD
Doxorubicin—AURKA—testis—germ cell cancer	8.49e-05	0.00249	CbGeAlD
Doxorubicin—DHCR7—midbrain—germ cell cancer	8.48e-05	0.00249	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—germ cell cancer	8.43e-05	0.00247	CbGeAlD
Doxorubicin—NDUFS3—female gonad—germ cell cancer	8.43e-05	0.00247	CbGeAlD
Doxorubicin—ABCC10—trigeminal ganglion—germ cell cancer	8.32e-05	0.00244	CbGeAlD
Doxorubicin—DHCR7—bone marrow—germ cell cancer	8.31e-05	0.00244	CbGeAlD
Doxorubicin—DHCR7—spinal cord—germ cell cancer	8.27e-05	0.00243	CbGeAlD
Doxorubicin—RALBP1—uterus—germ cell cancer	8.11e-05	0.00238	CbGeAlD
Doxorubicin—NQO1—eye—germ cell cancer	8.03e-05	0.00235	CbGeAlD
Doxorubicin—DHCR7—female gonad—germ cell cancer	8.01e-05	0.00235	CbGeAlD
Doxorubicin—NOS1—endocrine gland—germ cell cancer	7.98e-05	0.00234	CbGeAlD
Doxorubicin—RALBP1—pituitary gland—germ cell cancer	7.97e-05	0.00234	CbGeAlD
Doxorubicin—NQO1—retina—germ cell cancer	7.95e-05	0.00233	CbGeAlD
Doxorubicin—NDUFS2—endocrine gland—germ cell cancer	7.93e-05	0.00233	CbGeAlD
Doxorubicin—NOS1—head—germ cell cancer	7.88e-05	0.00231	CbGeAlD
Doxorubicin—YWHAG—adrenal gland—germ cell cancer	7.88e-05	0.00231	CbGeAlD
Doxorubicin—NDUFS3—endocrine gland—germ cell cancer	7.84e-05	0.0023	CbGeAlD
Doxorubicin—NDUFS2—head—germ cell cancer	7.83e-05	0.0023	CbGeAlD
Doxorubicin—POR—decidua—germ cell cancer	7.81e-05	0.00229	CbGeAlD
Doxorubicin—YWHAG—midbrain—germ cell cancer	7.78e-05	0.00228	CbGeAlD
Doxorubicin—NDUFS3—head—germ cell cancer	7.74e-05	0.00227	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—germ cell cancer	7.69e-05	0.00225	CbGeAlD
Doxorubicin—YWHAG—bone marrow—germ cell cancer	7.62e-05	0.00223	CbGeAlD
Doxorubicin—CBR1—gonad—germ cell cancer	7.62e-05	0.00223	CbGeAlD
Doxorubicin—NOS1—testis—germ cell cancer	7.61e-05	0.00223	CbGeAlD
Doxorubicin—YWHAG—spinal cord—germ cell cancer	7.59e-05	0.00223	CbGeAlD
Doxorubicin—CBR1—uterus—germ cell cancer	7.57e-05	0.00222	CbGeAlD
Doxorubicin—NDUFS2—testis—germ cell cancer	7.57e-05	0.00222	CbGeAlD
Doxorubicin—AKR1A1—brain—germ cell cancer	7.54e-05	0.00221	CbGeAlD
Doxorubicin—AKR1C3—uterus—germ cell cancer	7.48e-05	0.00219	CbGeAlD
Doxorubicin—NDUFS3—testis—germ cell cancer	7.47e-05	0.00219	CbGeAlD
Doxorubicin—DHCR7—endocrine gland—germ cell cancer	7.45e-05	0.00218	CbGeAlD
Doxorubicin—CBR1—pituitary gland—germ cell cancer	7.44e-05	0.00218	CbGeAlD
Doxorubicin—DHCR7—head—germ cell cancer	7.35e-05	0.00216	CbGeAlD
Doxorubicin—YWHAG—female gonad—germ cell cancer	7.35e-05	0.00215	CbGeAlD
Doxorubicin—AKR1C3—pituitary gland—germ cell cancer	7.34e-05	0.00215	CbGeAlD
Doxorubicin—NQO1—telencephalon—germ cell cancer	7.32e-05	0.00215	CbGeAlD
Doxorubicin—AKR1A1—lymph node—germ cell cancer	7.28e-05	0.00214	CbGeAlD
Doxorubicin—TOP2A—decidua—germ cell cancer	7.28e-05	0.00213	CbGeAlD
Doxorubicin—ABCC6—endocrine gland—germ cell cancer	7.26e-05	0.00213	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—germ cell cancer	7.18e-05	0.0021	CbGeAlD
Doxorubicin—ABCC6—head—germ cell cancer	7.16e-05	0.0021	CbGeAlD
Doxorubicin—RALBP1—adrenal gland—germ cell cancer	7.12e-05	0.00209	CbGeAlD
Doxorubicin—DHCR7—testis—germ cell cancer	7.1e-05	0.00208	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—germ cell cancer	7.09e-05	0.00208	CbGeAlD
Doxorubicin—NOS1—cerebellum—germ cell cancer	7.03e-05	0.00206	CbGeAlD
Doxorubicin—RALBP1—midbrain—germ cell cancer	7.03e-05	0.00206	CbGeAlD
Doxorubicin—NOS3—adrenal gland—germ cell cancer	7e-05	0.00205	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—germ cell cancer	6.99e-05	0.00205	CbGeAlD
Doxorubicin—NQO1—skin of body—germ cell cancer	6.98e-05	0.00205	CbGeAlD
Doxorubicin—NQO1—decidua—germ cell cancer	6.94e-05	0.00203	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—germ cell cancer	6.9e-05	0.00202	CbGeAlD
Doxorubicin—RALBP1—bone marrow—germ cell cancer	6.88e-05	0.00202	CbGeAlD
Doxorubicin—RALBP1—spinal cord—germ cell cancer	6.85e-05	0.00201	CbGeAlD
Doxorubicin—NDUFS7—brain—germ cell cancer	6.85e-05	0.00201	CbGeAlD
Doxorubicin—YWHAG—endocrine gland—germ cell cancer	6.83e-05	0.002	CbGeAlD
Doxorubicin—YWHAG—head—germ cell cancer	6.75e-05	0.00198	CbGeAlD
Doxorubicin—POR—pituitary gland—germ cell cancer	6.71e-05	0.00197	CbGeAlD
Doxorubicin—XDH—endocrine gland—germ cell cancer	6.66e-05	0.00195	CbGeAlD
Doxorubicin—CBR1—adrenal gland—germ cell cancer	6.64e-05	0.00195	CbGeAlD
Doxorubicin—RALBP1—female gonad—germ cell cancer	6.63e-05	0.00195	CbGeAlD
Doxorubicin—NDUFS7—lymph node—germ cell cancer	6.62e-05	0.00194	CbGeAlD
Doxorubicin—YWHAG—Cell Cycle—KITLG—germ cell cancer	6.6e-05	0.00356	CbGpPWpGaD
Doxorubicin—AKR1C3—adrenal gland—germ cell cancer	6.56e-05	0.00192	CbGeAlD
Doxorubicin—DHCR7—cerebellum—germ cell cancer	6.56e-05	0.00192	CbGeAlD
Doxorubicin—CBR1—midbrain—germ cell cancer	6.56e-05	0.00192	CbGeAlD
Doxorubicin—ABCC10—telencephalon—germ cell cancer	6.54e-05	0.00192	CbGeAlD
Doxorubicin—YWHAG—testis—germ cell cancer	6.52e-05	0.00191	CbGeAlD
Doxorubicin—ABCB11—endocrine gland—germ cell cancer	6.51e-05	0.00191	CbGeAlD
Doxorubicin—ABCC3—NRF2 pathway—SLC2A3—germ cell cancer	6.49e-05	0.0035	CbGpPWpGaD
Doxorubicin—AKR1C3—midbrain—germ cell cancer	6.48e-05	0.0019	CbGeAlD
Doxorubicin—POR—medulla oblongata—germ cell cancer	6.47e-05	0.0019	CbGeAlD
Doxorubicin—CBR1—bone marrow—germ cell cancer	6.43e-05	0.00188	CbGeAlD
Doxorubicin—NDUFS2—p73 transcription factor network—MYC—germ cell cancer	6.4e-05	0.00345	CbGpPWpGaD
Doxorubicin—CBR1—spinal cord—germ cell cancer	6.4e-05	0.00188	CbGeAlD
Doxorubicin—AURKA—brain—germ cell cancer	6.37e-05	0.00187	CbGeAlD
Doxorubicin—TOP2A—uterus—germ cell cancer	6.36e-05	0.00187	CbGeAlD
Doxorubicin—AKR1C3—bone marrow—germ cell cancer	6.35e-05	0.00186	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—germ cell cancer	6.32e-05	0.00185	CbGeAlD
Doxorubicin—YWHAG—Activation of BH3-only proteins—TP53—germ cell cancer	6.27e-05	0.00338	CbGpPWpGaD
Doxorubicin—ABCC3—decidua—germ cell cancer	6.22e-05	0.00182	CbGeAlD
Doxorubicin—ABCB11—testis—germ cell cancer	6.21e-05	0.00182	CbGeAlD
Doxorubicin—ABCC10—decidua—germ cell cancer	6.19e-05	0.00182	CbGeAlD
Doxorubicin—CBR1—female gonad—germ cell cancer	6.19e-05	0.00182	CbGeAlD
Doxorubicin—RALBP1—endocrine gland—germ cell cancer	6.17e-05	0.00181	CbGeAlD
Doxorubicin—AURKA—lymph node—germ cell cancer	6.15e-05	0.0018	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.14e-05	0.00331	CbGpPWpGaD
Doxorubicin—AKR1C3—female gonad—germ cell cancer	6.12e-05	0.00179	CbGeAlD
Doxorubicin—RALBP1—head—germ cell cancer	6.09e-05	0.00179	CbGeAlD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—germ cell cancer	6.08e-05	0.00328	CbGpPWpGaD
Doxorubicin—NOS3—endocrine gland—germ cell cancer	6.07e-05	0.00178	CbGeAlD
Doxorubicin—NQO1—uterus—germ cell cancer	6.07e-05	0.00178	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—AVP—germ cell cancer	6.05e-05	0.00326	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.05e-05	0.00326	CbGpPWpGaD
Doxorubicin—YWHAG—cerebellum—germ cell cancer	6.02e-05	0.00176	CbGeAlD
Doxorubicin—NOS3—head—germ cell cancer	5.99e-05	0.00176	CbGeAlD
Doxorubicin—POR—adrenal gland—germ cell cancer	5.99e-05	0.00176	CbGeAlD
Doxorubicin—NQO1—pituitary gland—germ cell cancer	5.96e-05	0.00175	CbGeAlD
Doxorubicin—POR—midbrain—germ cell cancer	5.91e-05	0.00173	CbGeAlD
Doxorubicin—RALBP1—testis—germ cell cancer	5.88e-05	0.00173	CbGeAlD
Doxorubicin—POR—bone marrow—germ cell cancer	5.8e-05	0.0017	CbGeAlD
Doxorubicin—NOS3—testis—germ cell cancer	5.79e-05	0.0017	CbGeAlD
Doxorubicin—POR—spinal cord—germ cell cancer	5.77e-05	0.00169	CbGeAlD
Doxorubicin—CBR1—endocrine gland—germ cell cancer	5.76e-05	0.00169	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—germ cell cancer	5.75e-05	0.00169	CbGeAlD
Doxorubicin—NOS1—brain—germ cell cancer	5.71e-05	0.00167	CbGeAlD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	5.7e-05	0.00307	CbGpPWpGaD
Doxorubicin—CBR1—head—germ cell cancer	5.69e-05	0.00167	CbGeAlD
Doxorubicin—NDUFS2—brain—germ cell cancer	5.68e-05	0.00166	CbGeAlD
Doxorubicin—CYP1B1—eye—germ cell cancer	5.64e-05	0.00165	CbGeAlD
Doxorubicin—NDUFS3—brain—germ cell cancer	5.61e-05	0.00164	CbGeAlD
Doxorubicin—POR—female gonad—germ cell cancer	5.59e-05	0.00164	CbGeAlD
Doxorubicin—TOP2A—adrenal gland—germ cell cancer	5.58e-05	0.00164	CbGeAlD
Doxorubicin—CBR1—testis—germ cell cancer	5.49e-05	0.00161	CbGeAlD
Doxorubicin—NDUFS2—lymph node—germ cell cancer	5.48e-05	0.00161	CbGeAlD
Doxorubicin—ABCC10—gonad—germ cell cancer	5.45e-05	0.0016	CbGeAlD
Doxorubicin—TOP2A—Vindesine—Vinblastine—germ cell cancer	5.45e-05	0.0443	CbGdCrCtD
Doxorubicin—RALBP1—cerebellum—germ cell cancer	5.43e-05	0.00159	CbGeAlD
Doxorubicin—AKR1C3—testis—germ cell cancer	5.43e-05	0.00159	CbGeAlD
Doxorubicin—ABCC10—uterus—germ cell cancer	5.42e-05	0.00159	CbGeAlD
Doxorubicin—NDUFS3—lymph node—germ cell cancer	5.42e-05	0.00159	CbGeAlD
Doxorubicin—TOP2A—bone marrow—germ cell cancer	5.4e-05	0.00158	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.37e-05	0.00289	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—OXT—germ cell cancer	5.35e-05	0.00289	CbGpPWpGaD
Doxorubicin—DHCR7—brain—germ cell cancer	5.33e-05	0.00156	CbGeAlD
Doxorubicin—NQO1—adrenal gland—germ cell cancer	5.32e-05	0.00156	CbGeAlD
Doxorubicin—ABCC10—pituitary gland—germ cell cancer	5.32e-05	0.00156	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.29e-05	0.00285	CbGpPWpGaD
Doxorubicin—NQO1—midbrain—germ cell cancer	5.25e-05	0.00154	CbGeAlD
Doxorubicin—TOP2A—female gonad—germ cell cancer	5.21e-05	0.00153	CbGeAlD
Doxorubicin—POR—endocrine gland—germ cell cancer	5.2e-05	0.00152	CbGeAlD
Doxorubicin—DHCR7—lymph node—germ cell cancer	5.15e-05	0.00151	CbGeAlD
Doxorubicin—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	5.15e-05	0.00277	CbGpPWpGaD
Doxorubicin—CYP1B1—telencephalon—germ cell cancer	5.14e-05	0.00151	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—germ cell cancer	5.13e-05	0.00151	CbGeAlD
Doxorubicin—NQO1—spinal cord—germ cell cancer	5.13e-05	0.0015	CbGeAlD
Doxorubicin—NOS1—Hemostasis—CD9—germ cell cancer	5.12e-05	0.00276	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.08e-05	0.00274	CbGpPWpGaD
Doxorubicin—CBR1—cerebellum—germ cell cancer	5.07e-05	0.00149	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—germ cell cancer	5.01e-05	0.00147	CbGeAlD
Doxorubicin—NQO1—female gonad—germ cell cancer	4.96e-05	0.00145	CbGeAlD
Doxorubicin—POR—testis—germ cell cancer	4.95e-05	0.00145	CbGeAlD
Doxorubicin—YWHAG—LKB1 signaling events—MYC—germ cell cancer	4.95e-05	0.00267	CbGpPWpGaD
Doxorubicin—CYP1B1—skin of body—germ cell cancer	4.9e-05	0.00144	CbGeAlD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	4.9e-05	0.00264	CbGpPWpGaD
Doxorubicin—YWHAG—brain—germ cell cancer	4.89e-05	0.00143	CbGeAlD
Doxorubicin—ABCG2—trigeminal ganglion—germ cell cancer	4.87e-05	0.00143	CbGeAlD
Doxorubicin—CYP1B1—decidua—germ cell cancer	4.87e-05	0.00143	CbGeAlD
Doxorubicin—ABCC3—adrenal gland—germ cell cancer	4.78e-05	0.0014	CbGeAlD
Doxorubicin—ABCC10—adrenal gland—germ cell cancer	4.75e-05	0.00139	CbGeAlD
Doxorubicin—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	4.75e-05	0.00256	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.74e-05	0.00256	CbGpPWpGaD
Doxorubicin—YWHAG—lymph node—germ cell cancer	4.72e-05	0.00138	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	4.71e-05	0.00254	CbGpPWpGaD
Doxorubicin—ABCC10—midbrain—germ cell cancer	4.69e-05	0.00138	CbGeAlD
Doxorubicin—ABCC1—telencephalon—germ cell cancer	4.62e-05	0.00136	CbGeAlD
Doxorubicin—TOP2A—testis—germ cell cancer	4.62e-05	0.00135	CbGeAlD
Doxorubicin—NQO1—endocrine gland—germ cell cancer	4.62e-05	0.00135	CbGeAlD
Doxorubicin—ABCC10—bone marrow—germ cell cancer	4.6e-05	0.00135	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—AVP—germ cell cancer	4.59e-05	0.00248	CbGpPWpGaD
Doxorubicin—ABCC10—spinal cord—germ cell cancer	4.58e-05	0.00134	CbGeAlD
Doxorubicin—POR—cerebellum—germ cell cancer	4.58e-05	0.00134	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.57e-05	0.00246	CbGpPWpGaD
Doxorubicin—NQO1—head—germ cell cancer	4.56e-05	0.00134	CbGeAlD
Doxorubicin—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	4.5e-05	0.00242	CbGpPWpGaD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—germ cell cancer	4.49e-05	0.00242	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—germ cell cancer	4.48e-05	0.00241	CbGpPWpGaD
Doxorubicin—ABCC3—female gonad—germ cell cancer	4.45e-05	0.00131	CbGeAlD
Doxorubicin—ABCC10—female gonad—germ cell cancer	4.43e-05	0.0013	CbGeAlD
Doxorubicin—RALBP1—brain—germ cell cancer	4.41e-05	0.00129	CbGeAlD
Doxorubicin—NQO1—testis—germ cell cancer	4.4e-05	0.00129	CbGeAlD
Doxorubicin—ABCC1—decidua—germ cell cancer	4.38e-05	0.00128	CbGeAlD
Doxorubicin—NOS3—brain—germ cell cancer	4.34e-05	0.00127	CbGeAlD
Doxorubicin—CYP1B1—gonad—germ cell cancer	4.29e-05	0.00126	CbGeAlD
Doxorubicin—RALBP1—lymph node—germ cell cancer	4.27e-05	0.00125	CbGeAlD
Doxorubicin—CYP1B1—uterus—germ cell cancer	4.26e-05	0.00125	CbGeAlD
Doxorubicin—NOS3—lymph node—germ cell cancer	4.2e-05	0.00123	CbGeAlD
Doxorubicin—CYP1B1—pituitary gland—germ cell cancer	4.18e-05	0.00123	CbGeAlD
Doxorubicin—ABCC3—endocrine gland—germ cell cancer	4.14e-05	0.00121	CbGeAlD
Doxorubicin—ABCC10—endocrine gland—germ cell cancer	4.12e-05	0.00121	CbGeAlD
Doxorubicin—CBR1—brain—germ cell cancer	4.12e-05	0.00121	CbGeAlD
Doxorubicin—ABCC3—head—germ cell cancer	4.09e-05	0.0012	CbGeAlD
Doxorubicin—AKR1C3—brain—germ cell cancer	4.07e-05	0.00119	CbGeAlD
Doxorubicin—NQO1—cerebellum—germ cell cancer	4.07e-05	0.00119	CbGeAlD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—germ cell cancer	4.06e-05	0.00219	CbGpPWpGaD
Doxorubicin—CBR1—lymph node—germ cell cancer	3.98e-05	0.00117	CbGeAlD
Doxorubicin—ABCC3—testis—germ cell cancer	3.95e-05	0.00116	CbGeAlD
Doxorubicin—AKR1C3—lymph node—germ cell cancer	3.93e-05	0.00115	CbGeAlD
Doxorubicin—ABCC10—testis—germ cell cancer	3.93e-05	0.00115	CbGeAlD
Doxorubicin—ABCB1—blood vessel—germ cell cancer	3.89e-05	0.00114	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	3.87e-05	0.00208	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—CD9—germ cell cancer	3.86e-05	0.00208	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—AVP—germ cell cancer	3.84e-05	0.00207	CbGpPWpGaD
Doxorubicin—ABCC1—uterus—germ cell cancer	3.83e-05	0.00112	CbGeAlD
Doxorubicin—ABCG2—telencephalon—germ cell cancer	3.83e-05	0.00112	CbGeAlD
Doxorubicin—ABCC2—adrenal gland—germ cell cancer	3.82e-05	0.00112	CbGeAlD
Doxorubicin—ABCC1—pituitary gland—germ cell cancer	3.76e-05	0.0011	CbGeAlD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	3.75e-05	0.00202	CbGpPWpGaD
Doxorubicin—CYP1B1—adrenal gland—germ cell cancer	3.74e-05	0.0011	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—AVP—germ cell cancer	3.74e-05	0.00201	CbGpPWpGaD
Doxorubicin—POR—brain—germ cell cancer	3.72e-05	0.00109	CbGeAlD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	3.7e-05	0.00199	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	3.69e-05	0.00199	CbGpPWpGaD
Doxorubicin—ABCC10—cerebellum—germ cell cancer	3.63e-05	0.00106	CbGeAlD
Doxorubicin—ABCG2—decidua—germ cell cancer	3.63e-05	0.00106	CbGeAlD
Doxorubicin—POR—lymph node—germ cell cancer	3.59e-05	0.00105	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.59e-05	0.00193	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	3.55e-05	0.00191	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—SLC2A3—germ cell cancer	3.53e-05	0.0019	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—SLC2A3—germ cell cancer	3.53e-05	0.0019	CbGpPWpGaD
Doxorubicin—CYP1B1—female gonad—germ cell cancer	3.49e-05	0.00102	CbGeAlD
Doxorubicin—NDUFS7—Metabolism—SLC22A3—germ cell cancer	3.47e-05	0.00187	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—SLC22A3—germ cell cancer	3.47e-05	0.00187	CbGpPWpGaD
Doxorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	3.45e-05	0.00186	CbGpPWpGaD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	3.44e-05	0.028	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—germ cell cancer	3.44e-05	0.0279	CbGdCrCtD
Doxorubicin—TOP2A—Teniposide—Etoposide—germ cell cancer	3.44e-05	0.0279	CbGdCrCtD
Doxorubicin—NOS1—Alzheimers Disease—TP53—germ cell cancer	3.39e-05	0.00183	CbGpPWpGaD
Doxorubicin—CYP2B6—skin of body—germ cell cancer	3.37e-05	0.000988	CbGeAlD
Doxorubicin—ABCC1—adrenal gland—germ cell cancer	3.36e-05	0.000986	CbGeAlD
Doxorubicin—TOP2A—lymph node—germ cell cancer	3.35e-05	0.000981	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—SLC2A3—germ cell cancer	3.32e-05	0.00179	CbGpPWpGaD
Doxorubicin—ABCC2—endocrine gland—germ cell cancer	3.31e-05	0.00097	CbGeAlD
Doxorubicin—NQO1—brain—germ cell cancer	3.3e-05	0.000968	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—SLC22A3—germ cell cancer	3.27e-05	0.00176	CbGpPWpGaD
Doxorubicin—CYP1B1—endocrine gland—germ cell cancer	3.24e-05	0.00095	CbGeAlD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	3.21e-05	0.00173	CbGpPWpGaD
Doxorubicin—CYP1B1—head—germ cell cancer	3.2e-05	0.000938	CbGeAlD
Doxorubicin—NQO1—lymph node—germ cell cancer	3.19e-05	0.000935	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.18e-05	0.00171	CbGpPWpGaD
Doxorubicin—ABCG2—uterus—germ cell cancer	3.17e-05	0.00093	CbGeAlD
Doxorubicin—ABCC2—testis—germ cell cancer	3.16e-05	0.000925	CbGeAlD
Doxorubicin—ABCC1—female gonad—germ cell cancer	3.13e-05	0.000919	CbGeAlD
Doxorubicin—ABCG2—pituitary gland—germ cell cancer	3.12e-05	0.000913	CbGeAlD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—germ cell cancer	3.1e-05	0.00167	CbGpPWpGaD
Doxorubicin—CYP1B1—testis—germ cell cancer	3.09e-05	0.000906	CbGeAlD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	3.01e-05	0.00162	CbGpPWpGaD
Doxorubicin—ABCG2—medulla oblongata—germ cell cancer	3.01e-05	0.000881	CbGeAlD
Doxorubicin—NOS3—Hemostasis—CD9—germ cell cancer	3e-05	0.00162	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—MYC—germ cell cancer	2.99e-05	0.00161	CbGpPWpGaD
Doxorubicin—ABCC3—brain—germ cell cancer	2.96e-05	0.000869	CbGeAlD
Doxorubicin—CYP2D6—brainstem—germ cell cancer	2.96e-05	0.000867	CbGeAlD
Doxorubicin—ABCC10—brain—germ cell cancer	2.95e-05	0.000865	CbGeAlD
Doxorubicin—CYP2B6—gonad—germ cell cancer	2.95e-05	0.000864	CbGeAlD
Doxorubicin—TOP2A—Vincristine—Vinblastine—germ cell cancer	2.94e-05	0.0239	CbGdCrCtD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	2.92e-05	0.00157	CbGpPWpGaD
Doxorubicin—ABCC3—lymph node—germ cell cancer	2.86e-05	0.00084	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—germ cell cancer	2.85e-05	0.000837	CbGeAlD
Doxorubicin—ABCC10—lymph node—germ cell cancer	2.85e-05	0.000835	CbGeAlD
Doxorubicin—NDUFS3—Metabolism—CRABP1—germ cell cancer	2.83e-05	0.00153	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CRABP1—germ cell cancer	2.83e-05	0.00153	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—AVP—germ cell cancer	2.83e-05	0.00153	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—SLC2A3—germ cell cancer	2.82e-05	0.00152	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	2.79e-05	0.0015	CbGpPWpGaD
Doxorubicin—ABCG2—adrenal gland—germ cell cancer	2.78e-05	0.000816	CbGeAlD
Doxorubicin—ABCC1—testis—germ cell cancer	2.78e-05	0.000815	CbGeAlD
Doxorubicin—DHCR7—Metabolism—SLC22A3—germ cell cancer	2.78e-05	0.0015	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	2.78e-05	0.0015	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—HRAS—germ cell cancer	2.76e-05	0.00149	CbGpPWpGaD
Doxorubicin—ABCG2—midbrain—germ cell cancer	2.75e-05	0.000806	CbGeAlD
Doxorubicin—Muscle spasms—Cisplatin—germ cell cancer	2.73e-05	0.000517	CcSEcCtD
Doxorubicin—Angiopathy—Etoposide—germ cell cancer	2.71e-05	0.000513	CcSEcCtD
Doxorubicin—Confusional state—Ifosfamide—germ cell cancer	2.71e-05	0.000513	CcSEcCtD
Doxorubicin—Immune system disorder—Etoposide—germ cell cancer	2.7e-05	0.000511	CcSEcCtD
Doxorubicin—Mediastinal disorder—Etoposide—germ cell cancer	2.69e-05	0.00051	CcSEcCtD
Doxorubicin—ABCG2—bone marrow—germ cell cancer	2.69e-05	0.000789	CbGeAlD
Doxorubicin—Pain—Bleomycin—germ cell cancer	2.69e-05	0.000509	CcSEcCtD
Doxorubicin—Anaphylactic shock—Ifosfamide—germ cell cancer	2.69e-05	0.000509	CcSEcCtD
Doxorubicin—Oedema—Ifosfamide—germ cell cancer	2.69e-05	0.000509	CcSEcCtD
Doxorubicin—ABCG2—spinal cord—germ cell cancer	2.68e-05	0.000786	CbGeAlD
Doxorubicin—Chills—Etoposide—germ cell cancer	2.68e-05	0.000508	CcSEcCtD
Doxorubicin—Vision blurred—Cisplatin—germ cell cancer	2.68e-05	0.000507	CcSEcCtD
Doxorubicin—Anaphylactoid reaction—Methotrexate—germ cell cancer	2.67e-05	0.000506	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	2.67e-05	0.000506	CcSEcCtD
Doxorubicin—Asthenia—Vinblastine—germ cell cancer	2.67e-05	0.000506	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.67e-05	0.00144	CbGpPWpGaD
Doxorubicin—Infection—Ifosfamide—germ cell cancer	2.67e-05	0.000506	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—CRABP1—germ cell cancer	2.66e-05	0.00144	CbGpPWpGaD
Doxorubicin—Alopecia—Etoposide—germ cell cancer	2.64e-05	0.0005	CcSEcCtD
Doxorubicin—Cerebrovascular accident—Methotrexate—germ cell cancer	2.64e-05	0.0005	CcSEcCtD
Doxorubicin—Lethargy—Methotrexate—germ cell cancer	2.64e-05	0.0005	CcSEcCtD
Doxorubicin—Nervous system disorder—Ifosfamide—germ cell cancer	2.64e-05	0.000499	CcSEcCtD
Doxorubicin—Ill-defined disorder—Cisplatin—germ cell cancer	2.63e-05	0.000499	CcSEcCtD
Doxorubicin—Thrombocytopenia—Ifosfamide—germ cell cancer	2.63e-05	0.000498	CcSEcCtD
Doxorubicin—CBR1—Metabolism—SLC2A3—germ cell cancer	2.63e-05	0.00142	CbGpPWpGaD
Doxorubicin—Anaemia—Cisplatin—germ cell cancer	2.62e-05	0.000497	CcSEcCtD
Doxorubicin—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	2.62e-05	0.00141	CbGpPWpGaD
Doxorubicin—CYP2D6—telencephalon—germ cell cancer	2.62e-05	0.000769	CbGeAlD
Doxorubicin—Skin disorder—Ifosfamide—germ cell cancer	2.61e-05	0.000494	CcSEcCtD
Doxorubicin—Hyperhidrosis—Ifosfamide—germ cell cancer	2.6e-05	0.000492	CcSEcCtD
Doxorubicin—ABCG2—female gonad—germ cell cancer	2.6e-05	0.000761	CbGeAlD
Doxorubicin—Feeling abnormal—Bleomycin—germ cell cancer	2.59e-05	0.000491	CcSEcCtD
Doxorubicin—CBR1—Metabolism—SLC22A3—germ cell cancer	2.59e-05	0.0014	CbGpPWpGaD
Doxorubicin—Osteoarthritis—Methotrexate—germ cell cancer	2.59e-05	0.00049	CcSEcCtD
Doxorubicin—ABCC1—cerebellum—germ cell cancer	2.57e-05	0.000753	CbGeAlD
Doxorubicin—CYP2B6—adrenal gland—germ cell cancer	2.57e-05	0.000753	CbGeAlD
Doxorubicin—Anorexia—Ifosfamide—germ cell cancer	2.56e-05	0.000485	CcSEcCtD
Doxorubicin—Malaise—Cisplatin—germ cell cancer	2.56e-05	0.000485	CcSEcCtD
Doxorubicin—NOS1—Disease—SLC2A3—germ cell cancer	2.55e-05	0.00138	CbGpPWpGaD
Doxorubicin—Decreased appetite—Dactinomycin—germ cell cancer	2.55e-05	0.000483	CcSEcCtD
Doxorubicin—Diarrhoea—Vinblastine—germ cell cancer	2.55e-05	0.000483	CcSEcCtD
Doxorubicin—Dysgeusia—Etoposide—germ cell cancer	2.55e-05	0.000482	CcSEcCtD
Doxorubicin—Leukopenia—Cisplatin—germ cell cancer	2.54e-05	0.000481	CcSEcCtD
Doxorubicin—Fatigue—Dactinomycin—germ cell cancer	2.53e-05	0.000479	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.52e-05	0.00136	CbGpPWpGaD
Doxorubicin—Back pain—Etoposide—germ cell cancer	2.52e-05	0.000477	CcSEcCtD
Doxorubicin—Hypotension—Ifosfamide—germ cell cancer	2.51e-05	0.000476	CcSEcCtD
Doxorubicin—Pain—Dactinomycin—germ cell cancer	2.51e-05	0.000475	CcSEcCtD
Doxorubicin—Muscle spasms—Etoposide—germ cell cancer	2.5e-05	0.000474	CcSEcCtD
Doxorubicin—Urticaria—Bleomycin—germ cell cancer	2.5e-05	0.000473	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.49e-05	0.00134	CbGpPWpGaD
Doxorubicin—Body temperature increased—Bleomycin—germ cell cancer	2.49e-05	0.000471	CcSEcCtD
Doxorubicin—AURKA—Cell Cycle—H2AFZ—germ cell cancer	2.48e-05	0.00134	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—AVP—germ cell cancer	2.47e-05	0.00133	CbGpPWpGaD
Doxorubicin—Dizziness—Vinblastine—germ cell cancer	2.46e-05	0.000466	CcSEcCtD
Doxorubicin—Convulsion—Cisplatin—germ cell cancer	2.46e-05	0.000466	CcSEcCtD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—germ cell cancer	2.46e-05	0.00132	CbGpPWpGaD
Doxorubicin—Mood swings—Methotrexate—germ cell cancer	2.45e-05	0.000464	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	2.45e-05	0.000464	CcSEcCtD
Doxorubicin—Ataxia—Methotrexate—germ cell cancer	2.43e-05	0.000461	CcSEcCtD
Doxorubicin—NOS3—SHP2 signaling—HRAS—germ cell cancer	2.43e-05	0.00131	CbGpPWpGaD
Doxorubicin—Myalgia—Cisplatin—germ cell cancer	2.42e-05	0.000458	CcSEcCtD
Doxorubicin—Feeling abnormal—Dactinomycin—germ cell cancer	2.42e-05	0.000458	CcSEcCtD
Doxorubicin—Paraesthesia—Ifosfamide—germ cell cancer	2.41e-05	0.000457	CcSEcCtD
Doxorubicin—Ill-defined disorder—Etoposide—germ cell cancer	2.41e-05	0.000457	CcSEcCtD
Doxorubicin—Anxiety—Cisplatin—germ cell cancer	2.41e-05	0.000456	CcSEcCtD
Doxorubicin—Anaemia—Etoposide—germ cell cancer	2.4e-05	0.000455	CcSEcCtD
Doxorubicin—ABCB1—trigeminal ganglion—germ cell cancer	2.4e-05	0.000704	CbGeAlD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	2.4e-05	0.000455	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dactinomycin—germ cell cancer	2.4e-05	0.000454	CcSEcCtD
Doxorubicin—Dyspnoea—Ifosfamide—germ cell cancer	2.4e-05	0.000454	CcSEcCtD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—MYC—germ cell cancer	2.39e-05	0.00129	CbGpPWpGaD
Doxorubicin—Somnolence—Ifosfamide—germ cell cancer	2.39e-05	0.000453	CcSEcCtD
Doxorubicin—Liver function test abnormal—Methotrexate—germ cell cancer	2.39e-05	0.000452	CcSEcCtD
Doxorubicin—Discomfort—Cisplatin—germ cell cancer	2.39e-05	0.000452	CcSEcCtD
Doxorubicin—Vomiting—Vinblastine—germ cell cancer	2.37e-05	0.000448	CcSEcCtD
Doxorubicin—Malaise—Etoposide—germ cell cancer	2.35e-05	0.000444	CcSEcCtD
Doxorubicin—Breast disorder—Methotrexate—germ cell cancer	2.34e-05	0.000443	CcSEcCtD
Doxorubicin—Vertigo—Etoposide—germ cell cancer	2.34e-05	0.000443	CcSEcCtD
Doxorubicin—Decreased appetite—Ifosfamide—germ cell cancer	2.34e-05	0.000443	CcSEcCtD
Doxorubicin—Headache—Vinblastine—germ cell cancer	2.33e-05	0.000442	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	2.33e-05	0.000441	CcSEcCtD
Doxorubicin—Leukopenia—Etoposide—germ cell cancer	2.33e-05	0.000441	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	2.32e-05	0.00044	CcSEcCtD
Doxorubicin—ABCB1—embryo—germ cell cancer	2.32e-05	0.00068	CbGeAlD
Doxorubicin—CYP1B1—brain—germ cell cancer	2.32e-05	0.00068	CbGeAlD
Doxorubicin—Abdominal pain—Dactinomycin—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Body temperature increased—Dactinomycin—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Fatigue—Ifosfamide—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Anaphylactic shock—Cisplatin—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Oedema—Cisplatin—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Hypersensitivity—Bleomycin—germ cell cancer	2.32e-05	0.000439	CcSEcCtD
Doxorubicin—Infection—Cisplatin—germ cell cancer	2.3e-05	0.000436	CcSEcCtD
Doxorubicin—ABCG2—testis—germ cell cancer	2.3e-05	0.000675	CbGeAlD
Doxorubicin—Pain—Ifosfamide—germ cell cancer	2.3e-05	0.000435	CcSEcCtD
Doxorubicin—Constipation—Ifosfamide—germ cell cancer	2.3e-05	0.000435	CcSEcCtD
Doxorubicin—ABCC2—lymph node—germ cell cancer	2.29e-05	0.000671	CbGeAlD
Doxorubicin—Loss of consciousness—Etoposide—germ cell cancer	2.29e-05	0.000433	CcSEcCtD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	2.28e-05	0.00123	CbGpPWpGaD
Doxorubicin—Nervous system disorder—Cisplatin—germ cell cancer	2.27e-05	0.00043	CcSEcCtD
Doxorubicin—Cough—Etoposide—germ cell cancer	2.27e-05	0.00043	CcSEcCtD
Doxorubicin—Thrombocytopenia—Cisplatin—germ cell cancer	2.27e-05	0.00043	CcSEcCtD
Doxorubicin—DHCR7—Metabolism—CRABP1—germ cell cancer	2.26e-05	0.00122	CbGpPWpGaD
Doxorubicin—Tachycardia—Cisplatin—germ cell cancer	2.26e-05	0.000428	CcSEcCtD
Doxorubicin—NOS2—Spinal Cord Injury—MYC—germ cell cancer	2.26e-05	0.00122	CbGpPWpGaD
Doxorubicin—Asthenia—Bleomycin—germ cell cancer	2.26e-05	0.000427	CcSEcCtD
Doxorubicin—Convulsion—Etoposide—germ cell cancer	2.25e-05	0.000427	CcSEcCtD
Doxorubicin—Skin disorder—Cisplatin—germ cell cancer	2.25e-05	0.000426	CcSEcCtD
Doxorubicin—Hypertension—Etoposide—germ cell cancer	2.25e-05	0.000425	CcSEcCtD
Doxorubicin—CYP1B1—lymph node—germ cell cancer	2.24e-05	0.000657	CbGeAlD
Doxorubicin—Hyperhidrosis—Cisplatin—germ cell cancer	2.24e-05	0.000424	CcSEcCtD
Doxorubicin—Asthma—Methotrexate—germ cell cancer	2.24e-05	0.000424	CcSEcCtD
Doxorubicin—CYP2B6—endocrine gland—germ cell cancer	2.23e-05	0.000653	CbGeAlD
Doxorubicin—Pruritus—Bleomycin—germ cell cancer	2.22e-05	0.000421	CcSEcCtD
Doxorubicin—Feeling abnormal—Ifosfamide—germ cell cancer	2.21e-05	0.00042	CcSEcCtD
Doxorubicin—Chest pain—Etoposide—germ cell cancer	2.21e-05	0.000419	CcSEcCtD
Doxorubicin—Eosinophilia—Methotrexate—germ cell cancer	2.21e-05	0.000419	CcSEcCtD
Doxorubicin—Nausea—Vinblastine—germ cell cancer	2.21e-05	0.000419	CcSEcCtD
Doxorubicin—Anorexia—Cisplatin—germ cell cancer	2.21e-05	0.000418	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	2.2e-05	0.000417	CcSEcCtD
Doxorubicin—CYP2B6—head—germ cell cancer	2.2e-05	0.000644	CbGeAlD
Doxorubicin—Gastrointestinal pain—Ifosfamide—germ cell cancer	2.2e-05	0.000416	CcSEcCtD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.2e-05	0.00118	CbGpPWpGaD
Doxorubicin—Pancreatitis—Methotrexate—germ cell cancer	2.19e-05	0.000415	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.19e-05	0.00118	CbGpPWpGaD
Doxorubicin—Discomfort—Etoposide—germ cell cancer	2.19e-05	0.000414	CcSEcCtD
Doxorubicin—Hypotension—Cisplatin—germ cell cancer	2.17e-05	0.00041	CcSEcCtD
Doxorubicin—Hypersensitivity—Dactinomycin—germ cell cancer	2.16e-05	0.000409	CcSEcCtD
Doxorubicin—Confusional state—Etoposide—germ cell cancer	2.14e-05	0.000405	CcSEcCtD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	2.14e-05	0.00115	CbGpPWpGaD
Doxorubicin—Urticaria—Ifosfamide—germ cell cancer	2.14e-05	0.000404	CcSEcCtD
Doxorubicin—ABCG2—cerebellum—germ cell cancer	2.13e-05	0.000623	CbGeAlD
Doxorubicin—Abdominal pain—Ifosfamide—germ cell cancer	2.12e-05	0.000402	CcSEcCtD
Doxorubicin—Body temperature increased—Ifosfamide—germ cell cancer	2.12e-05	0.000402	CcSEcCtD
Doxorubicin—CYP2B6—testis—germ cell cancer	2.12e-05	0.000623	CbGeAlD
Doxorubicin—Pancytopenia—Methotrexate—germ cell cancer	2.12e-05	0.000402	CcSEcCtD
Doxorubicin—Anaphylactic shock—Etoposide—germ cell cancer	2.12e-05	0.000402	CcSEcCtD
Doxorubicin—CBR1—Metabolism—CRABP1—germ cell cancer	2.11e-05	0.00114	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	2.11e-05	0.0004	CcSEcCtD
Doxorubicin—Infection—Etoposide—germ cell cancer	2.11e-05	0.000399	CcSEcCtD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—germ cell cancer	2.11e-05	0.00114	CbGpPWpGaD
Doxorubicin—Asthenia—Dactinomycin—germ cell cancer	2.1e-05	0.000399	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	2.1e-05	0.00113	CbGpPWpGaD
Doxorubicin—Dysuria—Methotrexate—germ cell cancer	2.09e-05	0.000396	CcSEcCtD
Doxorubicin—Neutropenia—Methotrexate—germ cell cancer	2.09e-05	0.000396	CcSEcCtD
Doxorubicin—ABCC1—brain—germ cell cancer	2.09e-05	0.000612	CbGeAlD
Doxorubicin—Paraesthesia—Cisplatin—germ cell cancer	2.08e-05	0.000394	CcSEcCtD
Doxorubicin—Thrombocytopenia—Etoposide—germ cell cancer	2.08e-05	0.000394	CcSEcCtD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.08e-05	0.00112	CbGpPWpGaD
Doxorubicin—Upper respiratory tract infection—Methotrexate—germ cell cancer	2.08e-05	0.000394	CcSEcCtD
Doxorubicin—Tachycardia—Etoposide—germ cell cancer	2.07e-05	0.000392	CcSEcCtD
Doxorubicin—Dyspnoea—Cisplatin—germ cell cancer	2.07e-05	0.000391	CcSEcCtD
Doxorubicin—Skin disorder—Etoposide—germ cell cancer	2.06e-05	0.000391	CcSEcCtD
Doxorubicin—Hyperhidrosis—Etoposide—germ cell cancer	2.05e-05	0.000389	CcSEcCtD
Doxorubicin—ABCB1—retina—germ cell cancer	2.05e-05	0.000601	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.05e-05	0.0011	CbGpPWpGaD
Doxorubicin—Photosensitivity reaction—Methotrexate—germ cell cancer	2.04e-05	0.000387	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	2.04e-05	0.0011	CbGpPWpGaD
Doxorubicin—Anorexia—Etoposide—germ cell cancer	2.02e-05	0.000383	CcSEcCtD
Doxorubicin—ABCC1—lymph node—germ cell cancer	2.02e-05	0.000591	CbGeAlD
Doxorubicin—Decreased appetite—Cisplatin—germ cell cancer	2.01e-05	0.000382	CcSEcCtD
Doxorubicin—Diarrhoea—Dactinomycin—germ cell cancer	2.01e-05	0.00038	CcSEcCtD
Doxorubicin—Pneumonia—Methotrexate—germ cell cancer	2.01e-05	0.00038	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Cisplatin—germ cell cancer	2e-05	0.000379	CcSEcCtD
Doxorubicin—Vomiting—Bleomycin—germ cell cancer	2e-05	0.000379	CcSEcCtD
Doxorubicin—Infestation—Methotrexate—germ cell cancer	1.99e-05	0.000378	CcSEcCtD
Doxorubicin—Drowsiness—Methotrexate—germ cell cancer	1.99e-05	0.000378	CcSEcCtD
Doxorubicin—Infestation NOS—Methotrexate—germ cell cancer	1.99e-05	0.000378	CcSEcCtD
Doxorubicin—Hypotension—Etoposide—germ cell cancer	1.98e-05	0.000376	CcSEcCtD
Doxorubicin—Rash—Bleomycin—germ cell cancer	1.98e-05	0.000376	CcSEcCtD
Doxorubicin—Pain—Cisplatin—germ cell cancer	1.98e-05	0.000375	CcSEcCtD
Doxorubicin—Dermatitis—Bleomycin—germ cell cancer	1.98e-05	0.000375	CcSEcCtD
Doxorubicin—Hypersensitivity—Ifosfamide—germ cell cancer	1.98e-05	0.000375	CcSEcCtD
Doxorubicin—NOS3—Leptin signaling pathway—HRAS—germ cell cancer	1.98e-05	0.00107	CbGpPWpGaD
Doxorubicin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	1.98e-05	0.000374	CcSEcCtD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	1.97e-05	0.00106	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—germ cell cancer	1.96e-05	0.00106	CbGpPWpGaD
Doxorubicin—Renal failure—Methotrexate—germ cell cancer	1.96e-05	0.000371	CcSEcCtD
Doxorubicin—Stomatitis—Methotrexate—germ cell cancer	1.94e-05	0.000368	CcSEcCtD
Doxorubicin—Conjunctivitis—Methotrexate—germ cell cancer	1.94e-05	0.000367	CcSEcCtD
Doxorubicin—Asthenia—Ifosfamide—germ cell cancer	1.93e-05	0.000365	CcSEcCtD
Doxorubicin—NOS2—Disease—SLC2A3—germ cell cancer	1.92e-05	0.00104	CbGpPWpGaD
Doxorubicin—Sweating—Methotrexate—germ cell cancer	1.91e-05	0.000362	CcSEcCtD
Doxorubicin—Feeling abnormal—Cisplatin—germ cell cancer	1.91e-05	0.000362	CcSEcCtD
Doxorubicin—Paraesthesia—Etoposide—germ cell cancer	1.91e-05	0.000361	CcSEcCtD
Doxorubicin—YWHAG—ErbB1 downstream signaling—HRAS—germ cell cancer	1.9e-05	0.00103	CbGpPWpGaD
Doxorubicin—Pruritus—Ifosfamide—germ cell cancer	1.9e-05	0.00036	CcSEcCtD
Doxorubicin—Haematuria—Methotrexate—germ cell cancer	1.9e-05	0.00036	CcSEcCtD
Doxorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.9e-05	0.00102	CbGpPWpGaD
Doxorubicin—Dyspnoea—Etoposide—germ cell cancer	1.89e-05	0.000358	CcSEcCtD
Doxorubicin—Somnolence—Etoposide—germ cell cancer	1.89e-05	0.000357	CcSEcCtD
Doxorubicin—ABCB1—telencephalon—germ cell cancer	1.89e-05	0.000553	CbGeAlD
Doxorubicin—Hepatobiliary disease—Methotrexate—germ cell cancer	1.89e-05	0.000357	CcSEcCtD
Doxorubicin—YWHAG—Cell Cycle—H2AFZ—germ cell cancer	1.88e-05	0.00101	CbGpPWpGaD
Doxorubicin—Epistaxis—Methotrexate—germ cell cancer	1.88e-05	0.000356	CcSEcCtD
Doxorubicin—Nausea—Bleomycin—germ cell cancer	1.87e-05	0.000354	CcSEcCtD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	1.87e-05	0.00101	CbGpPWpGaD
Doxorubicin—Vomiting—Dactinomycin—germ cell cancer	1.86e-05	0.000353	CcSEcCtD
Doxorubicin—Agranulocytosis—Methotrexate—germ cell cancer	1.86e-05	0.000352	CcSEcCtD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—germ cell cancer	1.85e-05	0.000999	CbGpPWpGaD
Doxorubicin—Rash—Dactinomycin—germ cell cancer	1.85e-05	0.00035	CcSEcCtD
Doxorubicin—Decreased appetite—Etoposide—germ cell cancer	1.85e-05	0.00035	CcSEcCtD
Doxorubicin—Diarrhoea—Ifosfamide—germ cell cancer	1.84e-05	0.000348	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Etoposide—germ cell cancer	1.83e-05	0.000347	CcSEcCtD
Doxorubicin—Body temperature increased—Cisplatin—germ cell cancer	1.83e-05	0.000347	CcSEcCtD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.83e-05	0.000987	CbGpPWpGaD
Doxorubicin—Fatigue—Etoposide—germ cell cancer	1.83e-05	0.000347	CcSEcCtD
Doxorubicin—Constipation—Etoposide—germ cell cancer	1.82e-05	0.000344	CcSEcCtD
Doxorubicin—Pain—Etoposide—germ cell cancer	1.82e-05	0.000344	CcSEcCtD
Doxorubicin—Haemoglobin—Methotrexate—germ cell cancer	1.8e-05	0.000341	CcSEcCtD
Doxorubicin—Haemorrhage—Methotrexate—germ cell cancer	1.79e-05	0.000339	CcSEcCtD
Doxorubicin—Hepatitis—Methotrexate—germ cell cancer	1.79e-05	0.000339	CcSEcCtD
Doxorubicin—ABCB1—decidua—germ cell cancer	1.79e-05	0.000524	CbGeAlD
Doxorubicin—CYP2D6—female gonad—germ cell cancer	1.78e-05	0.000522	CbGeAlD
Doxorubicin—Dizziness—Ifosfamide—germ cell cancer	1.78e-05	0.000337	CcSEcCtD
Doxorubicin—Pharyngitis—Methotrexate—germ cell cancer	1.78e-05	0.000336	CcSEcCtD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	1.77e-05	0.000957	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SLC2A3—germ cell cancer	1.77e-05	0.000953	CbGpPWpGaD
Doxorubicin—Urinary tract disorder—Methotrexate—germ cell cancer	1.77e-05	0.000335	CcSEcCtD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.76e-05	0.000946	CbGpPWpGaD
Doxorubicin—Urethral disorder—Methotrexate—germ cell cancer	1.75e-05	0.000332	CcSEcCtD
Doxorubicin—Feeling abnormal—Etoposide—germ cell cancer	1.75e-05	0.000331	CcSEcCtD
Doxorubicin—Nausea—Dactinomycin—germ cell cancer	1.74e-05	0.00033	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etoposide—germ cell cancer	1.74e-05	0.000329	CcSEcCtD
Doxorubicin—ABCG2—brain—germ cell cancer	1.73e-05	0.000506	CbGeAlD
Doxorubicin—Visual impairment—Methotrexate—germ cell cancer	1.72e-05	0.000327	CcSEcCtD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.72e-05	0.000929	CbGpPWpGaD
Doxorubicin—Vomiting—Ifosfamide—germ cell cancer	1.71e-05	0.000324	CcSEcCtD
Doxorubicin—Hypersensitivity—Cisplatin—germ cell cancer	1.71e-05	0.000323	CcSEcCtD
Doxorubicin—Rash—Ifosfamide—germ cell cancer	1.69e-05	0.000321	CcSEcCtD
Doxorubicin—Dermatitis—Ifosfamide—germ cell cancer	1.69e-05	0.000321	CcSEcCtD
Doxorubicin—Erythema multiforme—Methotrexate—germ cell cancer	1.69e-05	0.000321	CcSEcCtD
Doxorubicin—Urticaria—Etoposide—germ cell cancer	1.69e-05	0.000319	CcSEcCtD
Doxorubicin—CYP3A4—endocrine gland—germ cell cancer	1.68e-05	0.000493	CbGeAlD
Doxorubicin—Abdominal pain—Etoposide—germ cell cancer	1.68e-05	0.000318	CcSEcCtD
Doxorubicin—Body temperature increased—Etoposide—germ cell cancer	1.68e-05	0.000318	CcSEcCtD
Doxorubicin—Eye disorder—Methotrexate—germ cell cancer	1.67e-05	0.000317	CcSEcCtD
Doxorubicin—Tinnitus—Methotrexate—germ cell cancer	1.67e-05	0.000316	CcSEcCtD
Doxorubicin—ABCG2—lymph node—germ cell cancer	1.67e-05	0.000489	CbGeAlD
Doxorubicin—Asthenia—Cisplatin—germ cell cancer	1.66e-05	0.000315	CcSEcCtD
Doxorubicin—Cardiac disorder—Methotrexate—germ cell cancer	1.66e-05	0.000315	CcSEcCtD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—germ cell cancer	1.65e-05	0.000892	CbGpPWpGaD
Doxorubicin—CYP2D6—endocrine gland—germ cell cancer	1.65e-05	0.000485	CbGeAlD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.65e-05	0.000888	CbGpPWpGaD
Doxorubicin—CYP2D6—head—germ cell cancer	1.63e-05	0.000479	CbGeAlD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.63e-05	0.000878	CbGpPWpGaD
Doxorubicin—Angiopathy—Methotrexate—germ cell cancer	1.62e-05	0.000308	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.62e-05	0.000875	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	1.62e-05	0.000872	CbGpPWpGaD
Doxorubicin—Immune system disorder—Methotrexate—germ cell cancer	1.62e-05	0.000306	CcSEcCtD
Doxorubicin—Mediastinal disorder—Methotrexate—germ cell cancer	1.61e-05	0.000306	CcSEcCtD
Doxorubicin—Chills—Methotrexate—germ cell cancer	1.61e-05	0.000304	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.6e-05	0.000865	CbGpPWpGaD
Doxorubicin—Nausea—Ifosfamide—germ cell cancer	1.6e-05	0.000302	CcSEcCtD
Doxorubicin—CYP2B6—brain—germ cell cancer	1.59e-05	0.000467	CbGeAlD
Doxorubicin—Diarrhoea—Cisplatin—germ cell cancer	1.59e-05	0.0003	CcSEcCtD
Doxorubicin—Alopecia—Methotrexate—germ cell cancer	1.58e-05	0.0003	CcSEcCtD
Doxorubicin—CYP2D6—testis—germ cell cancer	1.58e-05	0.000463	CbGeAlD
Doxorubicin—ABCB1—gonad—germ cell cancer	1.57e-05	0.000462	CbGeAlD
Doxorubicin—Mental disorder—Methotrexate—germ cell cancer	1.57e-05	0.000297	CcSEcCtD
Doxorubicin—ABCB1—uterus—germ cell cancer	1.56e-05	0.000459	CbGeAlD
Doxorubicin—Hypersensitivity—Etoposide—germ cell cancer	1.56e-05	0.000296	CcSEcCtD
Doxorubicin—Malnutrition—Methotrexate—germ cell cancer	1.56e-05	0.000295	CcSEcCtD
Doxorubicin—Erythema—Methotrexate—germ cell cancer	1.56e-05	0.000295	CcSEcCtD
Doxorubicin—ABCB1—pituitary gland—germ cell cancer	1.54e-05	0.00045	CbGeAlD
Doxorubicin—NQO1—Metabolism—SLC2A3—germ cell cancer	1.54e-05	0.000828	CbGpPWpGaD
Doxorubicin—Dysgeusia—Methotrexate—germ cell cancer	1.53e-05	0.000289	CcSEcCtD
Doxorubicin—Asthenia—Etoposide—germ cell cancer	1.52e-05	0.000288	CcSEcCtD
Doxorubicin—NQO1—Metabolism—SLC22A3—germ cell cancer	1.51e-05	0.000815	CbGpPWpGaD
Doxorubicin—Back pain—Methotrexate—germ cell cancer	1.51e-05	0.000285	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—OXT—germ cell cancer	1.5e-05	0.000811	CbGpPWpGaD
Doxorubicin—Pruritus—Etoposide—germ cell cancer	1.5e-05	0.000284	CcSEcCtD
Doxorubicin—NOS3—Disease—SLC2A3—germ cell cancer	1.49e-05	0.000806	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	1.49e-05	0.000802	CbGpPWpGaD
Doxorubicin—ABCB1—medulla oblongata—germ cell cancer	1.48e-05	0.000435	CbGeAlD
Doxorubicin—AKR1C3—Metabolism—SLC2A3—germ cell cancer	1.48e-05	0.000798	CbGpPWpGaD
Doxorubicin—Vomiting—Cisplatin—germ cell cancer	1.47e-05	0.000279	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	1.47e-05	0.000793	CbGpPWpGaD
Doxorubicin—Vision blurred—Methotrexate—germ cell cancer	1.47e-05	0.000278	CcSEcCtD
Doxorubicin—NOS1—Disease—FGF4—germ cell cancer	1.47e-05	0.00079	CbGpPWpGaD
Doxorubicin—Rash—Cisplatin—germ cell cancer	1.46e-05	0.000277	CcSEcCtD
Doxorubicin—Dermatitis—Cisplatin—germ cell cancer	1.46e-05	0.000276	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—SLC22A3—germ cell cancer	1.46e-05	0.000787	CbGpPWpGaD
Doxorubicin—CYP2D6—cerebellum—germ cell cancer	1.46e-05	0.000427	CbGeAlD
Doxorubicin—YWHAG—Apoptosis—TP53—germ cell cancer	1.46e-05	0.000785	CbGpPWpGaD
Doxorubicin—Diarrhoea—Etoposide—germ cell cancer	1.45e-05	0.000275	CcSEcCtD
Doxorubicin—Ill-defined disorder—Methotrexate—germ cell cancer	1.45e-05	0.000274	CcSEcCtD
Doxorubicin—Anaemia—Methotrexate—germ cell cancer	1.44e-05	0.000273	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.43e-05	0.000772	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.41e-05	0.000761	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—HRAS—germ cell cancer	1.41e-05	0.000758	CbGpPWpGaD
Doxorubicin—Malaise—Methotrexate—germ cell cancer	1.4e-05	0.000266	CcSEcCtD
Doxorubicin—Dizziness—Etoposide—germ cell cancer	1.4e-05	0.000266	CcSEcCtD
Doxorubicin—Vertigo—Methotrexate—germ cell cancer	1.4e-05	0.000265	CcSEcCtD
Doxorubicin—Leukopenia—Methotrexate—germ cell cancer	1.39e-05	0.000264	CcSEcCtD
Doxorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	1.39e-05	0.000747	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SLC2A3—germ cell cancer	1.38e-05	0.000742	CbGpPWpGaD
Doxorubicin—Nausea—Cisplatin—germ cell cancer	1.38e-05	0.000261	CcSEcCtD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.38e-05	0.000741	CbGpPWpGaD
Doxorubicin—ABCB1—adrenal gland—germ cell cancer	1.37e-05	0.000402	CbGeAlD
Doxorubicin—Cough—Methotrexate—germ cell cancer	1.36e-05	0.000258	CcSEcCtD
Doxorubicin—XDH—Metabolism—SLC22A3—germ cell cancer	1.36e-05	0.000731	CbGpPWpGaD
Doxorubicin—ABCB1—midbrain—germ cell cancer	1.36e-05	0.000397	CbGeAlD
Doxorubicin—Convulsion—Methotrexate—germ cell cancer	1.35e-05	0.000256	CcSEcCtD
Doxorubicin—Vomiting—Etoposide—germ cell cancer	1.35e-05	0.000256	CcSEcCtD
Doxorubicin—Rash—Etoposide—germ cell cancer	1.34e-05	0.000254	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—germ cell cancer	1.34e-05	0.000253	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.33e-05	0.000717	CbGpPWpGaD
Doxorubicin—Headache—Etoposide—germ cell cancer	1.33e-05	0.000252	CcSEcCtD
Doxorubicin—ABCB1—bone marrow—germ cell cancer	1.33e-05	0.000389	CbGeAlD
Doxorubicin—Chest pain—Methotrexate—germ cell cancer	1.33e-05	0.000251	CcSEcCtD
Doxorubicin—Myalgia—Methotrexate—germ cell cancer	1.33e-05	0.000251	CcSEcCtD
Doxorubicin—Arthralgia—Methotrexate—germ cell cancer	1.33e-05	0.000251	CcSEcCtD
Doxorubicin—ABCB1—spinal cord—germ cell cancer	1.32e-05	0.000388	CbGeAlD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	1.32e-05	0.00025	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	1.32e-05	0.000709	CbGpPWpGaD
Doxorubicin—Discomfort—Methotrexate—germ cell cancer	1.31e-05	0.000248	CcSEcCtD
Doxorubicin—NOS1—Disease—H2AFZ—germ cell cancer	1.31e-05	0.000706	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FGF4—germ cell cancer	1.28e-05	0.000692	CbGpPWpGaD
Doxorubicin—Confusional state—Methotrexate—germ cell cancer	1.28e-05	0.000243	CcSEcCtD
Doxorubicin—ABCB1—female gonad—germ cell cancer	1.28e-05	0.000375	CbGeAlD
Doxorubicin—Anaphylactic shock—Methotrexate—germ cell cancer	1.27e-05	0.000241	CcSEcCtD
Doxorubicin—Infection—Methotrexate—germ cell cancer	1.26e-05	0.000239	CcSEcCtD
Doxorubicin—Nausea—Etoposide—germ cell cancer	1.26e-05	0.000239	CcSEcCtD
Doxorubicin—NOS3—Metabolism—SLC2A3—germ cell cancer	1.25e-05	0.000675	CbGpPWpGaD
Doxorubicin—Nervous system disorder—Methotrexate—germ cell cancer	1.25e-05	0.000236	CcSEcCtD
Doxorubicin—Thrombocytopenia—Methotrexate—germ cell cancer	1.24e-05	0.000236	CcSEcCtD
Doxorubicin—Skin disorder—Methotrexate—germ cell cancer	1.24e-05	0.000234	CcSEcCtD
Doxorubicin—NQO1—Metabolism—CRABP1—germ cell cancer	1.23e-05	0.000665	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC22A3—germ cell cancer	1.23e-05	0.000665	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Methotrexate—germ cell cancer	1.23e-05	0.000233	CcSEcCtD
Doxorubicin—Anorexia—Methotrexate—germ cell cancer	1.21e-05	0.00023	CcSEcCtD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—germ cell cancer	1.21e-05	0.000653	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KITLG—germ cell cancer	1.2e-05	0.000649	CbGpPWpGaD
Doxorubicin—ABCB1—endocrine gland—germ cell cancer	1.19e-05	0.000349	CbGeAlD
Doxorubicin—AKR1C3—Metabolism—CRABP1—germ cell cancer	1.19e-05	0.000641	CbGpPWpGaD
Doxorubicin—Hypotension—Methotrexate—germ cell cancer	1.19e-05	0.000225	CcSEcCtD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.18e-05	0.000638	CbGpPWpGaD
Doxorubicin—CYP2D6—brain—germ cell cancer	1.18e-05	0.000347	CbGeAlD
Doxorubicin—ABCB1—head—germ cell cancer	1.17e-05	0.000344	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	1.16e-05	0.000219	CcSEcCtD
Doxorubicin—Insomnia—Methotrexate—germ cell cancer	1.15e-05	0.000218	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—H2AFZ—germ cell cancer	1.15e-05	0.000618	CbGpPWpGaD
Doxorubicin—Paraesthesia—Methotrexate—germ cell cancer	1.14e-05	0.000216	CcSEcCtD
Doxorubicin—ABCB1—testis—germ cell cancer	1.14e-05	0.000333	CbGeAlD
Doxorubicin—Dyspnoea—Methotrexate—germ cell cancer	1.13e-05	0.000215	CcSEcCtD
Doxorubicin—Somnolence—Methotrexate—germ cell cancer	1.13e-05	0.000214	CcSEcCtD
Doxorubicin—Dyspepsia—Methotrexate—germ cell cancer	1.12e-05	0.000212	CcSEcCtD
Doxorubicin—XDH—Metabolism—CRABP1—germ cell cancer	1.11e-05	0.000596	CbGpPWpGaD
Doxorubicin—NOS2—Disease—FGF4—germ cell cancer	1.11e-05	0.000596	CbGpPWpGaD
Doxorubicin—Decreased appetite—Methotrexate—germ cell cancer	1.11e-05	0.000209	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Methotrexate—germ cell cancer	1.1e-05	0.000208	CcSEcCtD
Doxorubicin—Fatigue—Methotrexate—germ cell cancer	1.1e-05	0.000208	CcSEcCtD
Doxorubicin—Pain—Methotrexate—germ cell cancer	1.09e-05	0.000206	CcSEcCtD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	1.07e-05	0.000576	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KITLG—germ cell cancer	1.05e-05	0.000569	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.05e-05	0.000566	CbGpPWpGaD
Doxorubicin—ABCB1—cerebellum—germ cell cancer	1.05e-05	0.000307	CbGeAlD
Doxorubicin—Feeling abnormal—Methotrexate—germ cell cancer	1.05e-05	0.000198	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methotrexate—germ cell cancer	1.04e-05	0.000197	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—AVP—germ cell cancer	1.03e-05	0.000556	CbGpPWpGaD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.03e-05	0.000553	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—FGF4—germ cell cancer	1.02e-05	0.000548	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC2A3—germ cell cancer	1.02e-05	0.000547	CbGpPWpGaD
Doxorubicin—Urticaria—Methotrexate—germ cell cancer	1.01e-05	0.000191	CcSEcCtD
Doxorubicin—Abdominal pain—Methotrexate—germ cell cancer	1.01e-05	0.00019	CcSEcCtD
Doxorubicin—Body temperature increased—Methotrexate—germ cell cancer	1.01e-05	0.00019	CcSEcCtD
Doxorubicin—NOS3—Metabolism—CRABP1—germ cell cancer	1.01e-05	0.000542	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC22A3—germ cell cancer	1e-05	0.000539	CbGpPWpGaD
Doxorubicin—NOS2—Disease—H2AFZ—germ cell cancer	9.87e-06	0.000532	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC2A3—germ cell cancer	9.73e-06	0.000525	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC22A3—germ cell cancer	9.59e-06	0.000517	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—MYC—germ cell cancer	9.59e-06	0.000517	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—AVP—germ cell cancer	9.58e-06	0.000517	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Methotrexate—germ cell cancer	9.37e-06	0.000177	CcSEcCtD
Doxorubicin—Asthenia—Methotrexate—germ cell cancer	9.12e-06	0.000173	CcSEcCtD
Doxorubicin—ABCC1—Disease—SLC2A3—germ cell cancer	9.11e-06	0.000491	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KITLG—germ cell cancer	9.08e-06	0.00049	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—H2AFZ—germ cell cancer	9.07e-06	0.000489	CbGpPWpGaD
Doxorubicin—Pruritus—Methotrexate—germ cell cancer	9e-06	0.00017	CcSEcCtD
Doxorubicin—NOS1—Disease—FGFR3—germ cell cancer	8.95e-06	0.000482	CbGpPWpGaD
Doxorubicin—Diarrhoea—Methotrexate—germ cell cancer	8.7e-06	0.000165	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.62e-06	0.000465	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FGF4—germ cell cancer	8.58e-06	0.000463	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—germ cell cancer	8.57e-06	0.000462	CbGpPWpGaD
Doxorubicin—ABCB1—brain—germ cell cancer	8.51e-06	0.00025	CbGeAlD
Doxorubicin—Dizziness—Methotrexate—germ cell cancer	8.41e-06	0.000159	CcSEcCtD
Doxorubicin—AKR1C3—Disease—KITLG—germ cell cancer	8.35e-06	0.00045	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—OXT—germ cell cancer	8.34e-06	0.000449	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	8.28e-06	0.000446	CbGpPWpGaD
Doxorubicin—ABCB1—lymph node—germ cell cancer	8.23e-06	0.000241	CbGeAlD
Doxorubicin—NOS1—Disease—KIT—germ cell cancer	8.22e-06	0.000443	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CRABP1—germ cell cancer	8.15e-06	0.000439	CbGpPWpGaD
Doxorubicin—Vomiting—Methotrexate—germ cell cancer	8.08e-06	0.000153	CcSEcCtD
Doxorubicin—Rash—Methotrexate—germ cell cancer	8.02e-06	0.000152	CcSEcCtD
Doxorubicin—Dermatitis—Methotrexate—germ cell cancer	8.01e-06	0.000152	CcSEcCtD
Doxorubicin—Headache—Methotrexate—germ cell cancer	7.97e-06	0.000151	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—FGFR3—germ cell cancer	7.84e-06	0.000423	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CRABP1—germ cell cancer	7.82e-06	0.000421	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.75e-06	0.000418	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—germ cell cancer	7.67e-06	0.000413	CbGpPWpGaD
Doxorubicin—NOS3—Disease—H2AFZ—germ cell cancer	7.67e-06	0.000413	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.63e-06	0.000411	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC2A3—germ cell cancer	7.63e-06	0.000411	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	7.6e-06	0.00041	CbGpPWpGaD
Doxorubicin—Nausea—Methotrexate—germ cell cancer	7.55e-06	0.000143	CcSEcCtD
Doxorubicin—ABCC1—Metabolism—SLC22A3—germ cell cancer	7.51e-06	0.000405	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	7.51e-06	0.000405	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC2A3—germ cell cancer	7.38e-06	0.000398	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—germ cell cancer	7.33e-06	0.000395	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC22A3—germ cell cancer	7.27e-06	0.000392	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—germ cell cancer	7.27e-06	0.000392	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KIT—germ cell cancer	7.2e-06	0.000388	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGF4—germ cell cancer	7.11e-06	0.000383	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KITLG—germ cell cancer	7.05e-06	0.00038	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—OXT—germ cell cancer	7.04e-06	0.00038	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—germ cell cancer	7.04e-06	0.000379	CbGpPWpGaD
Doxorubicin—NOS2—Disease—FGFR3—germ cell cancer	6.75e-06	0.000364	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC2A3—germ cell cancer	6.71e-06	0.000362	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC22A3—germ cell cancer	6.61e-06	0.000356	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	6.61e-06	0.000356	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—germ cell cancer	6.5e-06	0.00035	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—H2AFZ—germ cell cancer	6.35e-06	0.000342	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—FGFR3—germ cell cancer	6.2e-06	0.000334	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KIT—germ cell cancer	6.2e-06	0.000334	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CRABP1—germ cell cancer	6.12e-06	0.00033	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGF4—germ cell cancer	6.01e-06	0.000324	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CRABP1—germ cell cancer	5.92e-06	0.000319	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KITLG—germ cell cancer	5.84e-06	0.000315	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—germ cell cancer	5.78e-06	0.000312	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AVP—germ cell cancer	5.71e-06	0.000308	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KIT—germ cell cancer	5.7e-06	0.000307	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—germ cell cancer	5.53e-06	0.000298	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CRABP1—germ cell cancer	5.39e-06	0.00029	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—H2AFZ—germ cell cancer	5.37e-06	0.000289	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	5.34e-06	0.000288	CbGpPWpGaD
Doxorubicin—NOS3—Disease—FGFR3—germ cell cancer	5.24e-06	0.000283	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGF4—germ cell cancer	5.23e-06	0.000282	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	5.08e-06	0.000274	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KITLG—germ cell cancer	4.94e-06	0.000266	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC2A3—germ cell cancer	4.92e-06	0.000265	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC22A3—germ cell cancer	4.85e-06	0.000261	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AVP—germ cell cancer	4.83e-06	0.00026	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KIT—germ cell cancer	4.81e-06	0.000259	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—H2AFZ—germ cell cancer	4.67e-06	0.000252	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—germ cell cancer	4.54e-06	0.000245	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—germ cell cancer	4.52e-06	0.000244	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—germ cell cancer	4.49e-06	0.000242	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FGFR3—germ cell cancer	4.34e-06	0.000234	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KITLG—germ cell cancer	4.3e-06	0.000232	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—germ cell cancer	4.3e-06	0.000232	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KIT—germ cell cancer	3.99e-06	0.000215	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—germ cell cancer	3.96e-06	0.000213	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CRABP1—germ cell cancer	3.95e-06	0.000213	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—germ cell cancer	3.73e-06	0.000201	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FGFR3—germ cell cancer	3.67e-06	0.000198	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A3—germ cell cancer	3.63e-06	0.000196	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC22A3—germ cell cancer	3.57e-06	0.000193	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.57e-06	0.000193	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—germ cell cancer	3.55e-06	0.000191	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.46e-06	0.000186	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A3—germ cell cancer	3.42e-06	0.000184	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—germ cell cancer	3.41e-06	0.000184	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KIT—germ cell cancer	3.37e-06	0.000182	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC22A3—germ cell cancer	3.37e-06	0.000182	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—germ cell cancer	3.25e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—FGFR3—germ cell cancer	3.19e-06	0.000172	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—germ cell cancer	3.13e-06	0.000169	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—germ cell cancer	3.11e-06	0.000168	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KIT—germ cell cancer	2.93e-06	0.000158	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CRABP1—germ cell cancer	2.91e-06	0.000157	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.84e-06	0.000153	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CRABP1—germ cell cancer	2.75e-06	0.000148	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—germ cell cancer	2.68e-06	0.000144	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—germ cell cancer	2.65e-06	0.000143	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—germ cell cancer	2.46e-06	0.000133	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.24e-06	0.00012	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.2e-06	0.000119	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—germ cell cancer	2.19e-06	0.000118	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—germ cell cancer	2.08e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—germ cell cancer	1.85e-06	9.99e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—germ cell cancer	1.8e-06	9.71e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.8e-06	9.68e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—germ cell cancer	1.72e-06	9.29e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—germ cell cancer	1.61e-06	8.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—germ cell cancer	1.52e-06	8.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—germ cell cancer	1.46e-06	7.85e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—germ cell cancer	1.27e-06	6.83e-05	CbGpPWpGaD
